Patent · US Active

Respiratory syncytial virus vaccine

US11464848B2 · kind B2 · utility

32Cited by

45References

17Claims

0Family size

Assignee

ModernaTX, Inc. · US

Inventors

Giuseppe Ciaramella · Sudbury, US
Kapil Bahl · Medford, US
Amy Espeseth · Forest Park, US
Dai Wang · Blue Bell, US
Andrew J. Bett · Lansdale, US

Key dates

Filing date	Mar 15, 2018
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Mar 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18534
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure describes respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.